Literature DB >> 15001665

International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor.

Charles Brink1, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F Evans, Douglas W P Hay, G Enrico Rovati, Charles N Serhan, Takao Shimizu, Takehiko Yokomizo.   

Abstract

Oxoeicosanoids are a family of biologically active arachidonic acid derivatives that have been intimately linked with cellular migration. These metabolites are not only potent chemotaxins but also elicit oxygen radical production as well as induce secretory events in different cells. The most potent native ligand reported is 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE), and the cell membrane receptor activated has now been cloned. This receptor is distinct from those receptors activated by either the prostaglandins or the leukotrienes. The purpose of this review is to briefly summarize the molecular evidence and highlight the significance of this receptor. In addition, an official nomenclature for this oxoeicosanoid receptor is proposed.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15001665     DOI： 10.1124/pr.56.1.4

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


  13 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Inhibition of 5-oxo-6,8,11,14-eicosatetraenoic acid-induced activation of neutrophils and eosinophils by novel indole OXE receptor antagonists.

Authors:  Vivek Gore; Sylvie Gravel; Chantal Cossette; Pranav Patel; Shishir Chourey; Qiuji Ye; Joshua Rokach; William S Powell
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

Review 3.  The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.

Authors:  William S Powell; Joshua Rokach
Journal:  Prog Lipid Res       Date:  2013-09-19       Impact factor: 16.195

Review 4.  Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.

Authors:  Magnus Bäck; William S Powell; Sven-Erik Dahlén; Jeffrey M Drazen; Jilly F Evans; Charles N Serhan; Takao Shimizu; Takehiko Yokomizo; G Enrico Rovati
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

5.  5-Oxo-ETE receptor antagonists.

Authors:  Vivek Gore; Pranav Patel; Chih-Tsung Chang; Sashikala Sivendran; Namin Kang; Yannick P Ouedraogo; Sylvie Gravel; William S Powell; Joshua Rokach
Journal:  J Med Chem       Date:  2013-04-26       Impact factor: 7.446

6.  Human neutrophils convert the sebum-derived polyunsaturated fatty acid Sebaleic acid to a potent granulocyte chemoattractant.

Authors:  Chantal Cossette; Pranav Patel; Jaganmohan R Anumolu; Sashikala Sivendran; Gue Jae Lee; Sylvie Gravel; François D Graham; Alain Lesimple; Orval A Mamer; Joshua Rokach; William S Powell
Journal:  J Biol Chem       Date:  2008-02-20       Impact factor: 5.157

Review 7.  5-Oxo-ETE and the OXE receptor.

Authors:  Gail E Grant; Joshua Rokach; William S Powell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-05-18       Impact factor: 3.072

8.  OXER1, a G protein-coupled oxoeicosatetraenoid receptor, mediates the survival-promoting effects of arachidonate 5-lipoxygenase in prostate cancer cells.

Authors:  Sivalokanathan Sarveswaran; Jagadananda Ghosh
Journal:  Cancer Lett       Date:  2013-05-02       Impact factor: 8.679

9.  ss-TEA: Entropy based identification of receptor specific ligand binding residues from a multiple sequence alignment of class A GPCRs.

Authors:  Marijn P A Sanders; Wilco W M Fleuren; Stefan Verhoeven; Sven van den Beld; Wynand Alkema; Jacob de Vlieg; Jan P G Klomp
Journal:  BMC Bioinformatics       Date:  2011-08-10       Impact factor: 3.169

Review 10.  Intercellular Lipid Mediators and GPCR Drug Discovery.

Authors:  Dong-Soon Im
Journal:  Biomol Ther (Seoul)       Date:  2013-11       Impact factor: 4.634
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.